143 related articles for article (PubMed ID: 35708863)
1. Polymorphic variants of the CASP3, CASP9, BCL-2 and NKX3-1 genes as candidate markers for prostate cancer susceptibility and poor prognosis.
de Souza MR; de Souza MF; de Nóbrega M; Cilião HL; Dos Reis MB; Fuganti PE; Cólus IMS
Mol Biol Rep; 2022 Sep; 49(9):9079-9087. PubMed ID: 35708863
[TBL] [Abstract][Full Text] [Related]
2. An
Furini HH; Fukushima KSSQ; DE Nóbrega M; DE Souza MF; Rodrigues MRS; DE Mattos BB; Guembarovski RL; Fuganti PE; Simão ANC; Flauzino T; Cólus IMS
Anticancer Res; 2023 Jan; 43(1):369-379. PubMed ID: 36585213
[TBL] [Abstract][Full Text] [Related]
3. Association of CASP3 genetic polymorphisms rs1049216, rs2705897 and rs4647603 with the risk of prostate cancer in Galicia (NW Spain).
López-Trigo N; Aguín N; Castuera IP; Rodríguez-Alonso A; Luis JR; Caeiro B
Gene; 2018 Dec; 679():126-132. PubMed ID: 30176316
[TBL] [Abstract][Full Text] [Related]
4. CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
Costa EFD; Lopes-Aguiar L; Nogueira GS; Lima TRP; Rinck-Junior JA; Lourenço GJ; Lima CSP
Head Neck; 2019 Aug; 41(8):2665-2670. PubMed ID: 30903678
[TBL] [Abstract][Full Text] [Related]
5. [Association of CASP3 and CASP9 polymorphisms with genetic susceptibility to stomach cancer].
Ni Q; Jiang X; Jin MJ; Liu B; Chen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):318-22. PubMed ID: 21644232
[TBL] [Abstract][Full Text] [Related]
6. The role of FASL, BCL-2 and BAX polymorphisms in brazilian patients with prostate cancer and benign prostatic hyperplasia.
da Silva Lawisch GK; Biolchi V; Kaufmann G; Nicolai G; Capitaneo E; Rosembach TR; Zang J; Brum IS; Chies JAB
Mol Biol Rep; 2022 Oct; 49(10):9445-9451. PubMed ID: 35988104
[TBL] [Abstract][Full Text] [Related]
7. A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression.
Akamatsu S; Takata R; Ashikawa K; Hosono N; Kamatani N; Fujioka T; Ogawa O; Kubo M; Nakamura Y; Nakagawa H
Hum Mol Genet; 2010 Nov; 19(21):4265-72. PubMed ID: 20716579
[TBL] [Abstract][Full Text] [Related]
8. [Association of prostate cancer with PDLIM5, SLC22A3 and NKX3-1 in Chinese men].
Hui J; Wang JY; Shi XH; Zhang YG; Liu M; Wang X; Wang NN; Chen X; Liang SY; Wei D; Zhao F; Zhang YH; Yang Z
Zhonghua Nan Ke Xue; 2012 May; 18(5):404-11. PubMed ID: 22741436
[TBL] [Abstract][Full Text] [Related]
9. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
10. Influence of CASP9 c.-1339A>G and CASP3 c.-1191A>G variants in outcome of patients with head and neck squamous cell carcinoma.
Carvalho BF; Costa EFD; Lopes-Aguiar L; Liutti VT; Leal F; Vasconcelos VCA; Rinck-Junior JA; Lourenço GJ; Lima CSP
J Oral Pathol Med; 2020 Nov; 49(10):1078-1083. PubMed ID: 32816327
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide 3'-UTR Single Nucleotide Polymorphism Association Study Identifies Significant Prostate Cancer Risk-Associated Functional Loci at 8p21.2 in Chinese Population.
Zhang N; Huang D; Jiang G; Chen S; Ruan X; Chen H; Huang J; Liu A; Zhang W; Lin X; Wu Y; Zhang Q; Li J; Tsu JH; Wei GH; Na R
Adv Sci (Weinh); 2022 Aug; 9(23):e2201420. PubMed ID: 35968571
[TBL] [Abstract][Full Text] [Related]
12. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Martinez EE; Darke AK; Tangen CM; Goodman PJ; Fowke JH; Klein EA; Abdulkadir SA
Cancer Prev Res (Phila); 2014 Sep; 7(9):950-7. PubMed ID: 24894197
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the expression of BAX, BCL2, BIRC6, CASP3, CASP9 apoptosis genes during the first episode of schizophrenia.
Szymona K; Dudzińska E; Karakuła-Juchnowicz H; Gil-Kulik P; Chomik P; Świstowska M; Gałaszkiewicz J; Kocki J
Psychiatr Pol; 2019 Dec; 53(6):1293-1303. PubMed ID: 32017818
[TBL] [Abstract][Full Text] [Related]
14. Association of the functional BCL-2 rs2279115 genetic variant and small cell lung cancer.
Yang X; Gao F; Ma F; Ren Y; Chen H; Liang X; Han S; Xiong X; Pan W; Zhou C; Zhou L; Yang M
Tumour Biol; 2016 Feb; 37(2):1693-8. PubMed ID: 26311051
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
[TBL] [Abstract][Full Text] [Related]
17. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.
Huang SP; Bao BY; Hour TC; Huang CY; Yu CC; Liu CC; Lee YC; Huang CN; Pao JB; Huang CH
PLoS One; 2012; 7(7):e41219. PubMed ID: 22844442
[TBL] [Abstract][Full Text] [Related]
19. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
20. Interaction of NKX3.1 and SELENOP genotype with prostate cancer recurrence.
Donadio JLS; Liu L; Freeman VL; Ekoue DN; Diamond AM; Bermano G
Prostate; 2019 Apr; 79(5):462-467. PubMed ID: 30582190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
